|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/20 | |||
| A61K 31/437 | |||
| A61K 33/10 | |||
| A61P 25/20 | |||
| A61K 9/46 | |||
| A61K 47/02 | |||
| A61K 9/50 | |||
| A61K 31/4985 |
| (11) | Number of the document | 2651391 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11799420.2 |
| Date of filing the European patent application | 2011-12-15 | |
| (97) | Date of publication of the European application | 2013-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/072933 |
| Date | 2011-12-15 |
| (87) | Number | WO 2012/080408 |
| Date | 2012-06-21 |
| (30) | Number | Date | Country code |
| 1060655 | 2010-12-16 | FR |
| (72) |
MARTINEZ, Annick, FR
ROUGEOT, Olivier, FR
YAGUCHI, Yoshikatsu, FR
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE |